Genbioma

Video-Pitch: https://vimeo.com/683306704

Description: Genbioma is a biotech startup with extensive experience in R&D, industrial development and commercialization of premium probiotic (live bacteria) and postbiotic (inactivated cells) ingredients with the ability to modulate the intestinal microbiota to improve long-term metabolic dysfunctions. Genbioma‘s activity is based on the development of pioneering technology for the regulation of glycemic metabolism and, therefore, the improvement of people’s health and quality of life, through rapid preclinical and clinical studies. In a first phase, Genbioma focuses on the development and commercialization of personalized and precision formulations based on microbiome, for the regulation of blood glucose, capable of providing an exceptional response maintained over time for people with different degrees of diabetes (prediabetes, Type 2 Diabetes, Gestational Diabetes). The efficacy of these products is based on the activity of a microbial strain, selected in previous studies carried out by the company as a microorganism with great potential in this field. The knowledge related to the design, scaling and production of this strain, with proven health effect to improve glucose regulation, is protected under international patent.

Web: www.genbioma.com